# Citations for Research Query

**Query:** # Disease Pathophysiology Research Template

## Target Disease
- **Disease Name:** Osteogenesis Imperfecta Type III
- **MONDO ID:**  (if available)
- **Category:** Mendelian

## Research Objectives

Please provide a comprehensive research report on the pathophysiology of **Osteogenesis Imperfecta Type III**.
Focus on the molecular and cellular mechanisms underlying disease progression.

### Required Information

#### 1. Core Pathophysiology
- What are the primary pathophysiological mechanisms?
- What molecular pathways are dysregulated?
- What cellular processes are affected?

#### 2. Key Molecular Players
- **Genes/Proteins**: Which genes are causally involved or implicated?
- **Chemical Entities**: What metabolites, drugs, or small molecules are relevant?
- **Cell Types**: Which cell types are primarily affected?
- **Anatomical Locations**: Which tissues/organs are involved?

#### 3. Biological Processes (for GO annotation)
- What biological processes (GO terms) are disrupted?
- Consider: signaling pathways, metabolic processes, cellular responses, transport, etc.

#### 4. Cellular Components
- Where in the cell do key processes occur?
- Consider: organelles, membrane compartments, extracellular space, etc.

#### 5. Disease Progression
- What is the sequence of events from initial trigger to clinical manifestation?
- Are there distinct stages or phases?

#### 6. Phenotypic Manifestations
- What are the key clinical phenotypes?
- How do they relate to the underlying mechanisms?

### Citation Requirements

- Cite primary literature (PMID preferred) for all mechanistic claims
- Prioritize recent reviews and landmark papers
- Include direct quotes where possible to support key statements

### Output Format

Structure your response as a narrative that could be used to populate a disease knowledge base entry with:
- Pathophysiology description
- Gene/protein annotations with ontology terms (HGNC, GO)
- Phenotype associations (HP terms)
- Cell type involvement (CL terms)
- Anatomical locations (UBERON terms)
- Chemical entities (CHEBI terms)
- Evidence items with PMIDs

**Provider:** falcon
**Generated:** 2026-02-04T19:43:23.978100

1. sillence2024adyadicnosology pages 11-12
2. sun2024emerginglandscapeof pages 3-4
3. sun2024emerginglandscapeof pages 5-6
4. sun2024emerginglandscapeof pages 6-7
5. sun2024emerginglandscapeof pages 4-5
6. sun2024emerginglandscapeof pages 2-3
7. verdonk2024isosteogenesisimperfecta pages 1-2
8. hald2024osteogenesisimperfectaskeletal pages 3-4
9. sun2024emerginglandscapeof pages 18-18
10. hald2024osteogenesisimperfectaskeletal pages 8-10
11. hald2024osteogenesisimperfectaskeletal pages 11-12
12. hald2024osteogenesisimperfectaskeletal pages 1-3
13. sillence2024adyadicnosology pages 9-11
14. sillence2024adyadicnosology pages 17-18
15. sillence2024adyadicnosology pages 16-17
16. hald2024osteogenesisimperfectaskeletal pages 6-8
17. and
18. https://doi.org/10.1021/acsptsci.3c00324
19. https://doi.org/10.1021/acsptsci.3c00324,
20. https://doi.org/10.1007/s00223-024-01248-7
21. https://doi.org/10.1007/s00223-024-01236-x
22. https://doi.org/10.1007/s00223-023-01171-3
23. https://doi.org/10.1007/s00223-024-01248-7,
24. https://doi.org/10.1186/s13023-023-02627-3
25. https://clinicaltrials.gov/study/NCT04545554
26. https://doi.org/10.1007/s00223-024-01236-x,
27. https://doi.org/10.1007/s00223-023-01171-3,